Jan Cornelis

Title: Jan Cornelis: Innovator in Brain Tumor Therapy

Introduction

Jan Cornelis is a notable inventor based in Neckargemünd, Germany. He has made significant contributions to the field of medical research, particularly in the treatment of brain tumors. His innovative approach utilizes parvoviruses as a therapeutic agent, showcasing the potential of viral therapies in oncology.

Latest Patents

Jan Cornelis holds a patent for the "Use of parvovirus for brain tumor therapy." This patent describes a method for treating brain tumors through a composition that includes various parvoviruses, such as parvovirus H1, LuIII, Mouse minute virus (MMV), Mouse parvovirus (MPV), Rat minute virus (RMV), Rat parvovirus (RPV), and Rat virus (RV). The patent also outlines the use of these parvoviruses in the preparation of pharmaceutical compositions aimed at treating brain tumors, including glioma, medulloblastoma, and meningioma.

Career Highlights

Jan Cornelis is affiliated with the Deutsches Krebsforschungszentrum Stiftung Des Öffentlichen Rechts, where he conducts his research. His work focuses on the intersection of virology and oncology, contributing to advancements in cancer treatment methodologies. His innovative research has the potential to change the landscape of brain tumor therapies.

Collaborations

Jan Cornelis has collaborated with esteemed colleagues such as Jean Rommelaere and Christiane Dinsart. These collaborations have further enriched his research and contributed to the development of effective treatment strategies for brain tumors.

Conclusion

Jan Cornelis is a pioneering inventor whose work in utilizing parvoviruses for brain tumor therapy represents a significant advancement in medical research. His contributions are paving the way for new therapeutic options in oncology.